Monkeypox Vaccine And Treatment Market Size, Share, Trends, Growth Outlook

Monkeypox Vaccine And Treatment Market is estimated to increase at a growth rate of 10.8% CAGR over the forecast period from 2024 to 2030.

The global Monkeypox Vaccine And Treatment Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Vaccine, Drugs, Vaccinia Immune Globulin (VIG), By Gender (Male, Female, Others), By Route of Administration (Oral, Injectable), By End-user (Hospitals, Specialty Clinics, Others).

An introduction to Monkeypox Vaccine And Treatment Market in 2024

Addressing emerging infectious threats, the Monkeypox Vaccine and Treatment market focuses on the development and deployment of vaccines, antiviral drugs, and supportive care interventions for preventing and managing monkeypox virus infections in humans. With outbreaks of monkeypox occurring sporadically, particularly in regions of Central and West Africa, efforts are underway to develop safe and effective vaccines and therapeutics to mitigate the impact of the disease on public health. The market's growth is driven by increasing awareness of zoonotic diseases, research investments in infectious disease preparedness, and collaborations between public health agencies, pharmaceutical companies, and research institutions to combat emerging viral pathogens.

Monkeypox Vaccine and Treatment Market Trend: Increased Global Awareness and Preparedness for Emerging Infectious Diseases

A significant trend in the monkeypox vaccine and treatment market is the increased global awareness and preparedness for emerging infectious diseases. With the recent outbreaks of monkeypox and other zoonotic diseases, there's a growing recognition of the need for effective vaccines and treatments to control the spread of these pathogens. This trend is driven by heightened public health concerns, international collaboration efforts, and advancements in vaccine development technologies. Governments, healthcare organizations, and pharmaceutical companies are investing in research and development initiatives to accelerate the development of monkeypox vaccines and treatments, as well as strengthening surveillance systems and response capabilities to mitigate the impact of future outbreaks. As awareness of the threat posed by emerging infectious diseases grows, there's an increasing focus on proactive measures to prevent and control outbreaks, driving investments and innovation in the monkeypox vaccine and treatment market.

Monkeypox Vaccine and Treatment Market Driver: Rising Incidence of Monkeypox Outbreaks and Zoonotic Transmission

The primary driver propelling the monkeypox vaccine and treatment market is the rising incidence of monkeypox outbreaks and zoonotic transmission events. Monkeypox, a viral disease closely related to smallpox, has emerged as a significant public health concern in recent years, particularly in Central and West Africa. The disease can be transmitted from animals to humans and between humans, leading to sporadic outbreaks with the potential for global dissemination. The increasing encroachment of human populations into wildlife habitats, along with changes in agricultural practices and international travel, has heightened the risk of zoonotic transmission and the spread of monkeypox to new geographic regions. This driver is reinforced by the urgent need to develop effective vaccines and treatments to control monkeypox outbreaks, protect vulnerable populations, and prevent further transmission of the virus.

Monkeypox Vaccine and Treatment Market Opportunity: Collaboration for Vaccine Development and Global Immunization Programs

An exciting opportunity in the monkeypox vaccine and treatment market lies in collaboration for vaccine development and global immunization programs. Given the complex nature of vaccine development and the limited resources available for research and clinical trials, collaboration among governments, academic institutions, pharmaceutical companies, and international organizations is essential to accelerate progress towards the development and licensure of monkeypox vaccines. Collaborative efforts can facilitate knowledge sharing, resource pooling, and coordination of research activities, enabling more efficient vaccine development pathways and expedited regulatory approvals. Additionally, collaboration on global immunization programs can help ensure equitable access to monkeypox vaccines for at-risk populations, particularly in low- and middle-income countries where the disease burden is highest. By fostering partnerships and leveraging collective expertise and resources, stakeholders can capitalize on this opportunity to address the unmet need for monkeypox vaccines and contribute to global health security efforts aimed at preventing and controlling infectious disease outbreaks.

Monkeypox Vaccine And Treatment Market Market Segmentation

By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Monkeypox Vaccine And Treatment Market Companies

Bavarian Nordic
Chimerix
EMERGENT
Gilead Sciences Inc
SIGA Technologies

Reasons to Buy the Monkeypox Vaccine And Treatment Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Monkeypox Vaccine And Treatment Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Monkeypox Vaccine And Treatment Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Monkeypox Vaccine And Treatment Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Monkeypox Vaccine And Treatment Market Size Outlook, $ Million, 2021 to 2030
3.2 Monkeypox Vaccine And Treatment Market Outlook by Type, $ Million, 2021 to 2030
3.3 Monkeypox Vaccine And Treatment Market Outlook by Product, $ Million, 2021 to 2030
3.4 Monkeypox Vaccine And Treatment Market Outlook by Application, $ Million, 2021 to 2030
3.5 Monkeypox Vaccine And Treatment Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Monkeypox Vaccine And Treatment Industry
4.2 Key Market Trends in Monkeypox Vaccine And Treatment Industry
4.3 Potential Opportunities in Monkeypox Vaccine And Treatment Industry
4.4 Key Challenges in Monkeypox Vaccine And Treatment Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Monkeypox Vaccine And Treatment Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Monkeypox Vaccine And Treatment Market Outlook by Segments
7.1 Monkeypox Vaccine And Treatment Market Outlook by Segments, $ Million, 2021- 2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

8 North America Monkeypox Vaccine And Treatment Market Analysis and Outlook To 2030
8.1 Introduction to North America Monkeypox Vaccine And Treatment Markets in 2024
8.2 North America Monkeypox Vaccine And Treatment Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Monkeypox Vaccine And Treatment Market size Outlook by Segments, 2021-2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

9 Europe Monkeypox Vaccine And Treatment Market Analysis and Outlook To 2030
9.1 Introduction to Europe Monkeypox Vaccine And Treatment Markets in 2024
9.2 Europe Monkeypox Vaccine And Treatment Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Monkeypox Vaccine And Treatment Market Size Outlook by Segments, 2021-2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

10 Asia Pacific Monkeypox Vaccine And Treatment Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Monkeypox Vaccine And Treatment Markets in 2024
10.2 Asia Pacific Monkeypox Vaccine And Treatment Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Monkeypox Vaccine And Treatment Market size Outlook by Segments, 2021-2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

11 South America Monkeypox Vaccine And Treatment Market Analysis and Outlook To 2030
11.1 Introduction to South America Monkeypox Vaccine And Treatment Markets in 2024
11.2 South America Monkeypox Vaccine And Treatment Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Monkeypox Vaccine And Treatment Market size Outlook by Segments, 2021-2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

12 Middle East and Africa Monkeypox Vaccine And Treatment Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Monkeypox Vaccine And Treatment Markets in 2024
12.2 Middle East and Africa Monkeypox Vaccine And Treatment Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Monkeypox Vaccine And Treatment Market size Outlook by Segments, 2021-2030
By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bavarian Nordic
Chimerix
EMERGENT
Gilead Sciences Inc
SIGA Technologies
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Vaccine
-JYNNEOS/ Imvanex
-Smallpox Vaccine
-Others
Drugs
-Tecovirimat
-Brincidofovir
-Cidofovir
-Others
Vaccinia Immune Globulin (VIG)
By Gender
Male
Female
Others
By Route of Administration
Oral
Injectable
By End-user
Hospitals
Specialty Clinics
Others